MedTrace Logo

Covid-19 Virtual Recovery Study

NCT04950725 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2268

Last updated 2023-08-21

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of respiratory muscle training (RMT) and nasal breathing on patients who have been infected with the SARS-CoV2 virus and continue to have lingering symptoms.

Conditions

  • Covid19

Interventions

BEHAVIORAL

Strength RMT

2 sets of 10 breaths twice per day using the breather or 3 sets of 10 breaths, twice per day using the Breather Fit

BEHAVIORAL

Strength RMT and nasal breathing

2 sets of 10 breaths twice per day using the Breather or 3 sets of 10 breaths twice per day using the Breather Fit. Subjects will also be asked to complete 2 sets of 10 nasal breathing exercises either before or after the RMT exercise.

BEHAVIORAL

Endurance RMT

15 breaths twice per day using the Breather or 20 breaths twice per day using the Breather Fit

BEHAVIORAL

Endurance RMT and nasal breathing

15 breaths twice per day using the Breather or 20 breaths twice per day using the Breather Fit at a lower intensity for a longer duration without break. Subjects will also perform 2 sets of 10 nasal breathing exercises either before or after the RMT exercise.

BEHAVIORAL

Low dose RMT

10 breaths, 3 times per week, at an intensity of 3 to 4 out of 10 using the Breather device.

Sponsors & Collaborators

Principal Investigators

  • Courtney M Wheatley-Guy, PhD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-12-31
Completion
2023-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04950725 on ClinicalTrials.gov